Antihypertensive drug: Difference between revisions

Line 99:

* [[valsartan]]

* [[Fimasartan]]

In 2004, an article in the [[BMJ]] examined the evidence for and against the suggestion that angiotensin receptor blockers may increase the risk of [[myocardial infarction]] (heart attack). The matter was debated in 2006 in the medical journal of the [[American Heart Association]]. There is no consensus on whether ARBs have a tendency to increase MI, but there is also no substantive evidence to indicate that ARBs are able to reduce MI.~~{{citation needed|date=July 2019}}~~

In 2004, an article in the [[BMJ]] examined the evidence for and against the suggestion that angiotensin receptor blockers may increase the risk of [[myocardial infarction]] (heart attack). The matter was debated in 2006 in the medical journal of the [[American Heart Association]]. There is no consensus on whether ARBs have a tendency to increase MI, but there is also no substantive evidence to indicate that ARBs are able to reduce MI.

Line 155:

==Vasodilators==

[[Vasodilator]]s act directly on the [[smooth muscle]] of arteries to relax their walls so blood can move more easily through them; they are only used in [[hypertensive emergency|hypertensive emergencies]] or when other drugs have failed, and even so are rarely given alone.~~{{cn|date=March 2023}}~~

[[Vasodilator]]s act directly on the [[smooth muscle]] of arteries to relax their walls so blood can move more easily through them; they are only used in [[hypertensive emergency|hypertensive emergencies]] or when other drugs have failed, and even so are rarely given alone.

Line 164:

==Aldosterone receptor antagonist==

[[Aldosterone]] receptor antagonists:~~{{cn|date=March 2023}}~~

[[Aldosterone]] receptor antagonists:

* [[eplerenone]]

* [[spironolactone]]

@@ Line 99: / Line 99: @@
 * [[valsartan]]
 * [[Fimasartan]]
-In 2004, an article in the [[BMJ]] examined the evidence for and against the suggestion that angiotensin receptor blockers may increase the risk of [[myocardial infarction]] (heart attack). The matter was debated in 2006 in the medical journal of the [[American Heart Association]]. There is no consensus on whether ARBs have a tendency to increase MI, but there is also no substantive evidence to indicate that ARBs are able to reduce MI.{{citation needed|date=July 2019}}
+In 2004, an article in the [[BMJ]] examined the evidence for and against the suggestion that angiotensin receptor blockers may increase the risk of [[myocardial infarction]] (heart attack). The matter was debated in 2006 in the medical journal of the [[American Heart Association]]. There is no consensus on whether ARBs have a tendency to increase MI, but there is also no substantive evidence to indicate that ARBs are able to reduce MI.
 <!--T:13-->
@@ Line 155: / Line 155: @@
 ==Vasodilators== <!--T:20-->
-[[Vasodilator]]s act directly on the [[smooth muscle]] of arteries to relax their walls so blood can move more easily through them; they are only used in [[hypertensive emergency|hypertensive emergencies]] or when other drugs have failed, and even so are rarely given alone.{{cn|date=March 2023}}
+[[Vasodilator]]s act directly on the [[smooth muscle]] of arteries to relax their walls so blood can move more easily through them; they are only used in [[hypertensive emergency|hypertensive emergencies]] or when other drugs have failed, and even so are rarely given alone.
 <!--T:21-->
@@ Line 164: / Line 164: @@
 ==Aldosterone receptor antagonist== <!--T:23-->
-[[Aldosterone]] receptor antagonists:{{cn|date=March 2023}}
+[[Aldosterone]] receptor antagonists:
 * [[eplerenone]]
 * [[spironolactone]]